Skip to main content
Figure 2 | Lipids in Health and Disease

Figure 2

From: Ezetimibe/Simvastatin 10/20 mg versus Rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency

Figure 2

Percent change in lipid and hs-CRP levels after 6 weeks of treatment in patients treated with high-potency statins* at baseline. *High potency stratum included: simvastatin 40 mg, atorvastatin 20 mg, rosuvastatin 5 mg Presented as median values Apo B = apolipoprotein B; E = ezetimibe; LDL-C = low-density lipoprotein cholesterol; HDL-C = high-density lipoprotein cholesterol; hs-CRP = high sensitivity C-reactive protein; R = rosuvastatin; S = simvastatin; TG = triglycerides; Total C = total cholesterol

Back to article page